Gene · 1787
Papers1,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization and differential expression of DNA methyltransferase and demethylase genes in response to abiotic stress in Isodon rubescens. | BMC Plant Biol | 2025 | 40468179 | PubTator, text mining | PubMed |
| RNA m5C modification: from physiology to pathology and its biological significance. | Front Immunol | 2025 | 40370440 | PubTator, text mining | PubMed |
| HuMSCs-derived exosomal YBX1 participates in oxidative damage repair in granulosa cells by stabilizing COX5B mRNA in an m5C-dependent manner. | Int J Biol Macromol | 2025 | 40253045 | PubTator, text mining | PubMed |
| Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data. | Front Pharmacol | 2025 | 40235543 | PubTator, text mining | PubMed |
| Paternal Effects in Mammalian Reproduction: Functional, Environmental, and Clinical Relevance of Sperm Components in Early Embryos and Beyond. | Mol Reprod Dev | 2025 | 40123230 | PubTator, text mining | PubMed |
| The multifaceted role of m5C RNA methylation in digestive system tumorigenesis. | Front Cell Dev Biol | 2025 | 40114967 | PubTator, text mining | PubMed |
| A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors. | Commun Chem | 2025 | 39900960 | PubTator, text mining | PubMed |
| Advanced reactivity-based sequencing methods for mRNA epitranscriptome profiling. | RSC Chem Biol | 2025 | 39759443 | PubTator, text mining | PubMed |
| Isoliquiritin targeting m5C RNA methylation improves mitophagy in doxorubicin-induced myocardial cardiotoxicity. | Phytomedicine | 2025 | 39657405 | PubTator, text mining | PubMed |
| tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10. | Cell Signal | 2025 | 39617358 | PubTator, text mining | PubMed |
| Looping forward: exploring R-loop processing and therapeutic potential. | FEBS Lett | 2025 | 38844597 | PubTator, text mining | PubMed |
| RNA Stability: A Review of the Role of Structural Features and Environmental Conditions. | Molecules | 2024 | 39770066 | PubTator, text mining | PubMed |
| The mechanism of sevoflurane affecting ovarian cancer cell proliferation and migration by regulating RNA methylase TRDMT1 to activate the β-catenin pathway. | Cell Biol Toxicol | 2024 | 39630363 | PubTator, text mining | PubMed |
| tRNA and tsRNA: From Heterogeneity to Multifaceted Regulators. | Biomolecules | 2024 | 39456272 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Berberine Inhibits KLF4 Promoter Methylation and Ferroptosis to Ameliorate Diabetic Nephropathy in Mice. | Chem Res Toxicol | 2024 | 39264844 | PubTator, text mining | PubMed |
| Epitranscriptomics and epigenetics: two sides of the same coin? | Clin Epigenetics | 2024 | 39252109 | PubTator, text mining | PubMed |
| B-Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy. | J Am Soc Nephrol | 2024 | 39137052 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma. | Medicine (Baltimore) | 2024 | 38905403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1787/papers?page=3